 |
|
Sign in to view your progression
|
|
ON-DEMAND
Immunotherapy in ovarian cancer: from biological findings to clinical trials
|
|
|
ON-DEMAND
Challenges and perspective for immunotherapy combinations in ovarian cancer
|
|
|
Q&A
Scientific session 4: Immune checkpoint inhibitors in ovarian cancer - lessons learnt and the road ahead - Q&A
|
|
{{ help_message }}
{{filter}}